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iabetic Coronary
rtery Disease
ow Little We Know and How Little
ntravascular Ultrasound Has Taught Us*
ary S. Mintz, MD, FACC
ew York, New York
oronary arteries in diabetic patients are typically described
s small, diffusely atherosclerotic with more distal involve-
ent and more prone to acute coronary events. What does
he intravascular ultrasound (IVUS) study by Nicholls et al.
1) in this issue of the Journal add to our understanding of
hese issues?
oronary Arteries in Diabetic
atients Are Described as Small
icholls et al. (1) reported that IVUS lumen volumes were
maller in diabetic patients compared with those in nondia-
etic patients.While it may be assumed that the corresponding
ngiograms would also show small lumen dimensions, IVUS
ersus angiographic lumen diameter comparisons consistently
how poor correlations.
See page 255
There are at least 3 potential mechanisms for angiographic-
lly small coronary arteries: 1) anatomically small arteries that
re nondominant, distal in location, supply limited amounts of
yocardium, or occur in women; 2) arteries that have a large
therosclerotic burden; and 3) arteries with negative remodel-
ng or impaired adaptive remodeling.
The authors showed that diabetic patients had more ath-
rosclerosis whether assessed by the absolute volume of ath-
rosclerotic plaque or the percent of external elastic membrane
EEM) occupied by plaque (percent atheroma volume calcu-
ated as [EEM  lumen]/EEM). However, the authors also
resented inferential data that remodeling was different in
iabetic patients compared with that in nondiabetic subjects.
What is remodeling? Remodeling is the change in arterial
or EEM) dimensions, typically in response to atheroscle-
otic plaque accumulation (2). It has been exhaustively
Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or thes
merican College of Cardiology.
From the Cardiovascular Research Foundation, New York, New York.tudied using pathology and IVUS; however, the literature
ontinues to be confusing because of the many definitions
nd methodologies used.
First, remodeling can be defined by comparing the lesion
EM to the reference (3–5): positive remodeling is a lesion
EM greater than the reference, intermediate remodeling is
lesion EEM roughly equivalent to the reference, and
egative remodeling is a lesion EEM smaller than the
eference. Although this is the most commonly used ap-
roach, there are limitations including reference site selec-
ion, the fact that reference segments have also undergone
emodeling, the impact of branch points, vessel tapering,
nd (as in the current study) the lack of well-defined lesions
r lesions with modest plaque burden (2).
Second, remodeling can be defined in terms of dynamic
hanges in arterial dimensions. An increase in EEM would
ndicate positive remodeling with an increase in EEM
xactly matching the increase in plaque indicating “perfect”
ositive remodeling, an increase in EEM greater than the
ncrease in plaque indicating excessive positive remodeling,
nd an increase in EEM less than the increase in plaque
ndicating inadequate positive remodeling. No change in
EM would indicate an absence of remodeling. A decrease
n EEM would indicate negative remodeling. Considering
hat the authors had serial IVUS data available for analysis,
his would seem to be the ideal approach. However, previ-
us serial IVUS studies have shown that baseline remodel-
ng (comparing the lesion EEM to the reference) does not
ecessarily predict serial IVUS findings (6,7). In the current
tudy, both diabetic subjects and nondiabetic subjects had
dentical decreases in EEM volume suggesting negative
emodeling in both groups. Decreases in EEM volumes can
e “primary” or can occur secondary to decreases in plaque
s was the case in both diabetic and nondiabetic groups.
hile arterial responses to plaque increase have been
xtensively studied, arterial responses to plaque decrease are
ot well known (8).
Third, remodeling can be inferred from “expected” base-
ine or serial IVUS measurements. The argument goes
omething like this. If EEM volumes are similar when
omparing 2 groups, then the group with more plaque had
ess adaptive positive remodeling because more plaque should
ave been associated with a larger EEM. Thus, because
iabetic subjects had a greater plaque volume at baseline, a
maller decrease in plaque volume at follow-up, and similar
aseline and serial measurements of EEM volume com-
ared with nondiabetic subjects, Nicholls et al. (1) con-
luded that compensatory positive remodeling was impaired
or negative remodeling was present) in diabetic subjects.
oronary Arteries in Diabetic
atients Are Described as Diffusely
therosclerotic With More Distal Involvement
he authors did not report the location of the analyzed


































































































264 Mintz JACC Vol. 52, No. 4, 2008
Editorial Comment July 22, 2008:263–5egments in diabetic subjects versus nondiabetic subjects.
owever, the authors did state: “Diabetic subjects did not
emonstrate more diffuse disease, as evidenced by a similar
ercentage of images containing plaque . . . as observed in
ondiabetic subjects” (1). It is hard to interpret this finding
ithout knowing whether a similar percentage of images
ere excluded in diabetic subjects compared with nondia-
etic subjects for reasons such as calcification, side branch
nvolvement, and imaging artifacts.
oronary Arteries in Diabetic Patients
re More Prone to Acute Coronary Events
he current study implies that atherosclerosis progression is
ne explanation for more events in diabetic subjects com-
ared with nondiabetic subjects. Proponents of the use of
VUS measures of progression/regression as surrogate end
oints have assumed that greater plaque progression must be
ssociated with more events. However, this may not be
orrect.
First, serial IVUS studies have shown only minimal
hanges in overall plaque volume or plaque burden. In the
urrent analysis, the change in absolute or percent atheroma
olume averaged only 1% to 2%. Similarly, the threshold for
ubstantial progression or regression was only a 5% relative
ncrease or decrease in percent atheroma volume (1).
Second, there may be significant heterogeneity among
atients and arterial segments. In the current study, 50% of
ll patients were substantial progressors while 35% were
ubstantial regressors.
Third, the arterial segment analyzed may not be repre-
entative of segments containing lesions that cause events.
ost acute events are caused by minimally stenotic lesions
hat progress rapidly, but comparing 2 or more lesions,
esions with the greatest lumen compromise most likely
ause events (9–11). As stated by Kern and Meier (11),
Because the aggregate risk of rupture associated with many
onsignificant lesions (each with an admittedly lower indi-
idual potential) exceeds that of the fewer significant le-
ions, a myocardial infarction will more likely originate from
nonsignificant lesion.” At the other end of the spectrum,
athologic studies have shown relatively few thin-capped
broatheromas (TCFAs), vulnerable plaques most likely to
ause events (12,13), making it unlikely that a “blindly”
elected 30-mm long coronary arterial segment would
ontain even 1 vulnerable plaque. The TCFAs accounted
or only 1.6% of the length of the coronary tree in patients
ying of cardiovascular causes (13).
Fourth, pathologic studies have shown that necrotic core
ize and fibrotic cap thickness and macrophage infiltration are
mong the factors that contribute to lesion stability/instability
12,14). Quantitative changes in atherosclerotic plaque mass
ay not reflect changes in plaque stability or composition—
ven if the analyzed segment fortuitously contains a TCFA. In
ddition, one consistent predictor of lesion instability is posi- cive remodeling (5); yet in the current analysis, diabetic subjects
ad less positive remodeling.
Fifth, some antiatherosclerotic drugs can have paradoxic,
dverse clinical effects and cause an increase in events. There-
ore, recent studies such as the ILLUSTRATE (Investigation
f Lipid Level Management Using Coronary Ultrasound to
ssess Reduction of Atherosclerosis by Cholesteryl Ester
ransfer Protein Inhibition and High-Density Lipoprotein
levation) trial and the ILLUMINATE (Investigation of
ipid Level Management to Understand Its Impact in Ath-
rosclerotic Events) trial suggest that clinical trials may be
nevitable and not obviated by surrogate end point studies
15,16).
Finally, the primary end point used in most grayscale
VUS end point trials—the absolute change in percent
theroma volume—may be too sensitive. Percent atheroma
olume can be as affected by remodeling as by progression
nd regression. Negative remodeling alone can increase
ercent atheroma volume whereas positive remodeling alone
an decrease percent atheroma volume. In the current study,
ercent atheroma volume increased whereas absolute ather-
ma volume decreased in both diabetic subjects and nondi-
betic subjects.
ow Little We Still Know
icholls et al. (1) are to be congratulated for having
ublished the largest, most completely analyzed study of
iabetic subjects with coronary artery disease—2,237 pa-
ients studied using serial volumetric IVUS. The amount of
ork involved is staggering. Nevertheless, in comparison
ith the profound clinical differences between diabetic
atients and nondiabetic subjects (and among subpopula-
ions of diabetic patients), the IVUS findings in the current
tudy are modest, somewhat internally inconsistent, and
artially at odds with pathologic data (17). Thus, if any-
hing, the analysis by Nicholls et al. (1) highlights the
imitations of grayscale IVUS. Perhaps, after almost 2
ecades of work and thousands of publications, the revela-
ions of IVUS have reached a plateau.
Just as IVUS was a step beyond angiography, it is now
ashionable to point to new imaging modalities such as
irtual histology or integrated backscatter IVUS, palpog-
aphy, optical imaging, spectroscopy, and so on as tech-
ologies that are a step beyond IVUS. Although in their
elative infancy, these techniques have the potential to
ssess changes in plaque composition and stability rather
han just overall changes in atherosclerosis volume. It is
he instability of the disease, not just the increase in
laque mass, that is different in high-risk patient subsets.
owever, these new techniques will yield significant
nformation only with careful patient and coronary artery
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